Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
National Institutes of Health
Horizon 2020 Framework Programme
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Carriage of rare APOB variants predisposes to severe steatotic liver disease and hepatocellular carcinoma
Daniel J. Schaid, Carolin Victoria Schneider, Lorenzo Miano, Mirella Fraquelli et al.
Journal
Journal of Clinical Investigation
Topics
Liver Disease Diagnosis and Treatment
article
Carriage of rare APOB variants predisposes to severe steatotic liver disease and hepatocellular carcinoma
Daniel J. Schaid, Carolin Victoria Schneider, Lorenzo Miano, Mirella Fraquelli, Marco Saracino, Rosellina Margherita Mancina, Vincenzo La Mura, Matteo Mureddu, Hadi Eidgah Torghabehei, Daniele Prati, Luisa Ronzoni, Luca Miele, Roberta D'Ambrosio, Robertino Dilena, Oveis Jamialahmadi, Vittoria Moretti, Julie A. Lynch, Josephine P. Johnson, Saleh A. Alqahtani, Giulia Periti, Salvatore Petta, Serena Pelusi, Stefano Romeo, Elisabetta Bugianesi, Francesco Paolo Russo, Paolo Parini, Alessandro Cherubini, Francesco Malvestiti, Luca V.C. Valenti, Kyong-Mi Chang
article en
Abstract
No abstract available for this paper.
Publication Tag
Journal of Clinical Investigation
Institutions
Karolinska University Hospital (SE), University of Padua (IT), Università Campus Bio-Medico (IT), VA Palo Alto Health Care System (US), University of Pavia (IT), King Faisal Specialist Hospital & Research Centre (SA), Agostino Gemelli University Polyclinic (IT), Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT), VA Salt Lake City Healthcare System (US), University of Palermo (AR), University of Pennsylvania (US), University of Gothenburg (SE), RWTH Aachen University (DE), University of Palermo (IT)
Funders
U.S. Department of Veterans Affairs, Amgen, Pfizer, AstraZeneca, Sanofi, Office of Research and Development, Celgene, Ultragenyx Pharmaceutical, European Commission, Ministero della Salute, Novo Nordisk, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, National Institutes of Health, Horizon 2020 Framework Programme